DNASE2 - Drug Target (Biomarker) (G1777)

Target Name: DNASE2

NCBI ID: G1777

DNASE2

DNASE2 - Drug Target (Biomarker)

Drug targets are proteins that are targeted by drugs to inhibit their activity or stimulate a response in the cell. These targets can be internal to the cell, such as inside the cell's DNA, or external, such as on the cell's surface. The identification of potential drug targets is a crucial step in the development of new pharmaceuticals. In this article, we will explore one such target protein called DNASE2 and its potential as a drug target.

The protein encoded by the gene DNASE2 is a member of the DNA-binding proteins family. This family of proteins includes enzymes that are involved in the repair of DNA damage. DNASE2 is a non-protein alpha-helicase enzyme that uses ATP to remove DNA double-strand breaks from a damaged strand.

DNASE2 is a critical enzyme in the repair of DNA damage that occurs during cell division. When a cell divides, its DNA is replicated, and if there is a mistake during the replication process, it can lead to a DNA double-strand break. DNASE2 is able to recognize and remove these double-strand breaks, allowing the cell to continue to divide and replicate its DNA without errors.

DNASE2 is also involved in the regulation of gene expression. When a cell is exposed to stress, such as radiation or chemicals, DNASE2 can help to prevent the activation of genes that would lead to cell death. This is important because when cells are subjected to stress, they are more susceptible to damage and can undergo apoptosis, which is a programmed cell death.

DNASE2 has also been shown to play a role in the regulation of cellular senescence. Senescence is the process by which cells become less productive and eventually die. DNASE2 has been shown to promote the production of reactive oxygen species (ROS) in cells, which can contribute to cellular senescence.

In addition to its role in DNA repair and cell regulation, DNASE2 has also been shown to be a potential drug target. The use of drugs that target DNASE2 has been shown to be effective in treating a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising uses for DNASE2 as a drug target is its potential to treat cancer. DNase2 has been shown to play a role in the development and progression of many types of cancer, including breast, ovarian, and colorectal cancers. By inhibiting the activity of DNASE2, researchers have been able to reduce the formation of blood vessels that feed these tumors, which can lead to a reduction in tumor growth.

Another promising application of DNase2 as a drug target is its potential to treat neurodegenerative diseases. Many neurodegenerative diseases, such as Alzheimer's and Parkinson's, are characterized by the progressive loss of brain cells. DNase2 has been shown to play a role in the production of these neurodegenerative diseases, and may be a useful target for new treatments.

In addition to its potential as a cancer and neurodegenerative disease treatment, DNase2 has also been shown to be a potential biomarker. The DNase2 gene has been shown to be expressed in a variety of tissues and cells, including cancer cells, neuroblasts, and glial cells. This suggests that DNase2 may be a useful biomarker for the diagnosis and monitoring of these diseases.

In conclusion, DNase2 is a protein that has been shown to play a critical role in the repair of DNA damage and regulation of cell division. Its potential as a drug target for cancer and neurodegenerative diseases makes it an important area of research. Further studies are needed to fully understand the role of DNase2

Protein Name: Deoxyribonuclease 2, Lysosomal

Functions: Hydrolyzes DNA under acidic conditions with a preference for double-stranded DNA. Plays a major role in the clearance of nucleic acids generated through apoptosis, hence preventing autoinflammation (PubMed:29259162, PubMed:31775019). Necessary for proper fetal development and for definitive erythropoiesis in fetal liver and bone marrow, where it degrades nuclear DNA expelled from erythroid precursor cells (PubMed:29259162)

The "DNASE2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DNASE2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets